The modern-day threat landscape requires enterprise security teams to think and act beyond traditional cybersecurity measures that are purely passive and reactive, and in most cases, ineffective against emerging threats and sophisticated threat actors. Prioritizing cybersecurity means implementing more proactive, adaptive, and actionable measures that can work together to effectively address the
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
